;
Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/15 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Piper Jaffray Edward Tenthoff Upgrade Overweight (from neutral) 26% $9.25 Wells…

    Published on 8/18/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/8 cls Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) -16% $4.04 Henry …

    Published on 8/11/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/1 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Piper Jaffray David Amsellem Downgrade Neutral (from overweight) -36% $6.89 …

    Published on 8/4/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/25 cls Gilead Sciences Inc. (NASDAQ:GILD) BMO Capital Markets Jim Birchenough Price target Outperform 1% $89.84 Birchenough raised …

    Published on 7/28/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/18 cls Genfit S.A. (Euronext:GNFT) Deutsche Bank Alethia Young New Buy 23% €29.50 Young initiated coverage with a €110 target on …

    Published on 7/21/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/11 cls Amicus Therapeutics Inc. (NASDAQ:FOLD) Janney Capital Markets Kimberly Lee Upgrade Buy (from hold) -1% $3.96 Leerink …

    Published on 7/14/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/27 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Wells Fargo Brian Abrahams Upgrade Outperform (from market perform) 6% $12.52 …

    Published on 6/30/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/20 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Maxim Group Jason Kolbert Price target Buy 26% $8.13 Kolbert raised his target …

    Published on 6/23/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/13 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Upgrade Outperform (from neutral) 125% $6.47 UBS Andrew …

    Published on 6/16/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/6 cls Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) Credit Suisse Jason Kantor New Outperform 46% $15.72 Leerink Partners Joseph …

    Published on 6/9/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/30 cls Acura Pharmaceuticals Inc. (NASDAQ:ACUR) MLV Graig Suvannavejh Downgrade Hold (from buy) -14% $1.06 Suvannavejh also lowered…

    Published on 6/2/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/23 cls InterMune Inc. (NASDAQ:ITMN) Leerink Partners Howard Liang Upgrade Outperform (from market perform) 17% $39.98 Stifel, …

    Published on 5/26/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/16 cls Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) Summer Street Jim Molloy New Buy 19% $280.26 Molloy initiated coverage with a $…

    Published on 5/19/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/9 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Cowen Nicholas Bishop Downgrade Market perform (from outperform) -25% $32.62 …

    Published on 5/12/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/2cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Bernstein Research Geoffrey Porges Upgrade Outperform (from market perform) 1% $155.…

    Published on 5/5/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/25 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Brinson Patrick Christopher James New Market outperform -4% $8.01 James …

    Published on 4/28/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/17 cls Akebia Therapeutics Inc. (NASDAQ:AKBA) UBS Matthew Roden New Buy 55% $26.09 Roden initiated coverage with a $28 target on …

    Published on 4/21/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/11 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) JPMorgan Geoffrey Meacham Upgrade Overweight (from neutral) 22% $43.32 Meacham also…

    Published on 4/14/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/4 cls GlycoMimetics Inc. (NASDAQ:GLYC) Jefferies Biren Amin Price target Buy 4% $15.77 Amin raised his target to $20 from $13 after…

    Published on 4/7/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/28 cls Endocyte Inc. (NASDAQ:ECYT) Leerink Partners Howard Liang Price target Market perform -22% $21.96 Wedbush Gregory Wade …

    Published on 3/31/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/21 cls Horizon Pharma Inc. (NASDAQ:HZNP) Cowen Edward Nash Price target Outperform 32% $17.35 Piper Jaffray Charles Duncan Price …

    Published on 3/24/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/14 cls Geron Corp. (NASDAQ:GERN) MLV Graig Suvannavejh Downgrade Hold (from buy) -60% $1.83 Piper Jaffray Charles Duncan …

    Published on 3/17/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/7 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) -4% $328.75 …

    Published on 3/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/28 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Maxim Group Echo He Upgrade Buy (from hold) -2% $8.69 Echo He upgraded and set an $…

    Published on 3/3/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/21 cls NPS Pharmaceuticals Inc. (NASDAQ:NPSP) Jefferies Eun Yang Downgrade Hold (from buy) 4% $38.57 Yang downgraded on valuation …

    Published on 2/24/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993